E 2 ofmay improve risk stratification of these patients and lead to tailored treatment. Cardiac computed tomography (CT) has been used to detect CAD at an early stage [6]. Coronary artery calcium score (CS) is a marker of atherosclerosis used to predict the likelihood of significant CAD and myocardial ischaemia, with low radiation exposure and no need of contrast agent. However, it can miss non-ca
Ulness of CTA or functional tests in screening asymptomatic diabetics [5,7,8,14]. No study to date has demonstrated additional value of CS and CTA when associated to clinical variables and classic risk scores, such as Framingham. This study aims to assess the additional benefit of CS and CTA, when added to clinical risk stratification schemes, to predict fatal and non fatal cardiovascular events i